#aaeth ,,congress #b;d ,session ,h4 ,r4 #ebbh ,,an ,,act ,to strengthen the authorities of the ,food and ,drug ,administration to address counterfeit drugs1 illegal and synthetic opioids1 and opioid-like substances1 and for other purposes4 #a4 ,short title2 table of contents 7a7 ,short title ,this ,act may be cited as the ,stop ,counterfeit ,drugs by ,regulating and ,enhancing ,enforcement ,now ,act or the ,,screen ,act4 7b7 ,table of contents ,the table of contents of this ,act is as follows3 ,sec4 #a4 ,short title2 table of contents4 ,sec4 #b4 ,detention1 refusal1 and destruction of drugs offered for importation4 ,sec4 #c4 ,notification1 nondistribution1 and recall of adulterated or misbranded drug products4 ,sec4 #d4 ,single source pattern of shipments of adulterated or misbranded drugs4 ,sec4 #e4 ,fund to strengthen efforts of ,,fda to combat the opioid and substance use epidemic4 ,sec4 #f4 ,consideration of potential for misuse and abuse required for drug approval4 #b4 ,detention1 refusal1 and destruction of drugs offered for importation 7a7 ,increasing the maximum dollar amount of drugs subject to destruction ,the sixth sentence in section #hja7;a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cha7;a77 is amended by striking except that the ,secretary and all that follows through the two periods at the end and inserting except that the ,secretary of ,health and ,human ,services may destroy1 without the opportunity for export1 any drug refused admission under this section1 if such drug is declared to be valued at an amount that is #b1ejj or less 7or such higher amount as the ,secretary of the ,treasury may set by regulation pursuant to section #dih7;a77#a7 of the ,tariff ,act of #aicj or such higher amount as the ,commissioner of ,food and ,drugs may set based on a finding by the ,commissioner that the higher amount is in the interest of public health71 or if such drug is entering the ,united ,states by mail1 and was not brought into compliance as described under subsection 7b744 7b7 ,destruction of articles of concern ,the sixth sentence of section #hja7;a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cha7;a771 as amended by subsection 7a71 is further amended by inserting before the period at the end the following3 2 and the ,secretary of ,health and ,human ,services may destroy1 without the opportunity for export1 any article refused admission under clause 7#f7 of the third sentence of this subsection4 7c7 ,technical amendments ,the seventh1 eighth1 and ninth sentences of section #hja7;a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cha7;a77 are amended-- 7#a7 by striking a drug each place it appears and inserting an article2 and 7#b7 by striking the drug each place it appears and inserting the article4 7d7 ,rule of construction ,the last sentence in section #hja7;a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cha7;a77 is amended to read as follows3 ,clauses 7#b71 7#e71 and 7#f7 of the third sentence of this subsection shall not be construed to prohibit the admission of narcotic or nonnarcotic drugs or other substances1 the importation of which is permitted under the ,controlled ,substances ,import and ,export ,act44 #c4 ,notification1 nondistribution1 and recall of adulterated or misbranded drug products 7a7 ,prohibited ,acts ,section #cja of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cca7 is amended by adding at the end the following3 7eee7 ,the failure to comply with any order issued under section #efi;,d4 4 7b7 ,notification1 nondistribution1 and recall of adulterated or misbranded drugs ,subchapter ,e of chapter ,v of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bbb et seq47 is amended by adding at the end the following3 #efi;,d4 ,notification1 ,nondistribution1 ,and ,recall ,of ,adulterated ,or ,misbranded ,drugs 7a7 ,order ,to cease distribution and recall 7#a7 ,in general ,upon a determination that the use or consumption of1 or exposure to1 a drug may present an imminent or substantial hazard to the public health1 the ,secretary shall issue an order requiring any person who distributes the drug to immediately cease distribution of the drug4 7#b7 ,hearing ,an order under paragraph 7#a7 shall provide the person subject to the order with an opportunity for an informal hearing1 to be held not later than #aj days after the date of issuance of the order1 on-- 7,a7 the actions required by the order2 and 7,b7 whether the order should be amended to require a recall of the drug4 7#c7 ,inadequate grounds ,if1 after providing an opportunity for a hearing under paragraph 7#b71 the ,secretary determines that inadequate grounds exist to support the actions required by the order1 the ,secretary shall vacate the order4 7#d7 ,amendment to order to require recall ,if1 after providing an opportunity for an informal hearing under paragraph 7#b71 the ,secretary determines that the order should be amended to include a recall of the drug with respect to which the order was issued1 the ,secretary shall-- 7,a7 amend the order to require a recall2 and 7,b7 after consultation with the drug sponsor1 specify a timetable in which the recall will occur4 7#e7 ,notice to persons affected ,an order under this subsection shall require any person who distributes the drug to provide for notice1 including to individuals as appropriate1 to persons who may be affected by the order to cease distribution of or recall the drug1 as applicable4 7#f7 ,action following order ,any person who is subject to an order under paragraph 7#a7 or 7#d7 shall immediately cease distribution of or recall1 as applicable1 the drug and provide notification as required by such order4 7b7 ,notice to consumers and health officials ,the ,secretary shall1 as the ,secretary determines to be necessary1 provide notice of a recall order under this section to-- 7#a7 consumers to whom the drug was1 or may have been1 distributed2 and 7#b7 appropriate ,state and local health officials4 7c7 ,order ,to recall 7#a7 ,contents ,an order to recall a drug under subsection 7a7 shall-- 7,a7 require periodic reports to the ,secretary describing the progress of the recall2 and 7,b7 provide for notice1 including to individuals as appropriate1 to persons who may be affected by the recall4 7#b7 ,assistance allowed ,in providing for notice under paragraph 7#a77;,b71 the ,secretary may allow for the assistance of health professionals1 ,state or local officials1 or other individuals designated by the ,secretary4 7#c7 ,nondelegation ,an order under this section shall be ordered by the ,secretary or an official designated by the ,secretary4 ,an official may not be so designated under this section unless the official is the ,director of the ,center for ,drug ,evaluation and ,research1 is an official senior to such ,director1 or is so designated by such ,director4 7d7 ,savings clause ,nothing contained in this section shall be construed as limiting-- 7#a7 the authority of the ,secretary to issue an order to cease distribution of1 or to recall1 an drug under any other provision of this ,act or the ,public ,health ,service ,act2 or 7#b7 the ability of the ,secretary to request any person to perform a voluntary activity related to any drug subject to this ,act or the ,public ,health ,service ,act4 4 7c7 ,drugs subject to refusal ,the third sentence of subsection 7a7 of section #hja of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cha7 is amended by inserting or 7#e7 in the case of a drug1 such drug is subject to an order under section #efh to cease distribution of or recall the drug1 before then such article shall be refused admission4 7d7 ,application ,sections #cja7;eee7 and #efi;,d of the ,federal ,food1 ,drug1 and ,cosmetic ,act1 as added by subsections 7a7 and 7b71 shall apply with respect to a drug as of such date1 not later than #a year after the date of the enactment of this ,act1 as the ,secretary of ,health and ,human ,services shall specify4 #d4 ,single source pattern of shipments of adulterated or misbranded drugs ,section #hja of the ,federal ,food1 ,drug1 and ,cosmetic ,act is amended by adding at the end the following3 7t7 ,single source pattern of shipments of adulterated or misbranded drugs ,if the ,secretary identifies a pattern of adulterated or misbranded drugs being offered for import from the same manufacturer1 distributor1 or importer1 the ,secretary may by order choose to treat all drugs being offered for import from such manufacturer1 distributor1 or importer as adulterated or misbranded unless otherwise demonstrated4 4 #e4 ,fund to strengthen efforts of ,,fda to combat the opioid and substance use epidemic ,chapter ,x of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cia et seq47 is amended by adding at the end the following3 #ajae4 ,fund to strengthen efforts of ,,fda to combat the opioid and substance use epidemic 7a7 ,in general ,the ,commissioner of ,food and ,drugs shall use any funds appropriated pursuant to the authorization of appropriations under subsection 7c7 to carry out the programs and activities described in subsection 7d7 to strengthen and facilitate the ,food and ,drug ,administration's efforts to address the opioid and substance use epidemic4 ,such funds shall be in addition to any funds which are otherwise available to carry out such programs and activities4 7b7 ,,fda ,opioid and ,substance ,use ,epidemic ,response ,fund 7#a7 ,establishment of fund ,there is established in the ,treasury a fund1 to be known as the ,,fda ,opioid and ,substance ,use ,epidemic ,response ,fund 7referred to in this subsection as the ,fund71 for purposes of funding the programs and activities described in subsection 7d74 7#b7 ,transfer ,for the period of fiscal years #bjai through #bjbc1 #aaj1jjj1jjj shall be transferred to the ,fund from the general fund of the ,treasury4 7#c7 ,amounts deposited ,any amounts transferred under paragraph 7#b7 shall remain unavailable in the ,fund until such amounts are appropriated pursuant to subsection 7c74 7c7 ,appropriations 7#a7 ,authorization of appropriations ,for the period of fiscal years #bjai through #bjbc1 there is authorized to be appropriated from the ,fund to the ,food and ,drug ,administration1 for the purpose of carrying out the programs and activities described in subsection 7d71 an amount not to exceed the total amount transferred to the ,fund under subsection 7b77#b74 ,notwithstanding subsection 7g71 such funds shall remain available until expended4 7#b7 ,offsetting future appropriations ,for any of fiscal years #bjai through #bjbc1 for any discretionary appropriation out of the ,fund to the ,food and ,drug ,administration pursuant to the authorization of appropriations under paragraph 7#a7 for the purpose of carrying out the programs and activities described in subsection 7d71 the total amount of such appropriations for the applicable fiscal year 7not to exceed the total amount remaining in the ,fund7 shall be subtracted from the estimate of discretionary budget authority and the resulting outlays for any estimate under the ,congressional ,budget and ,impoundment ,control ,act of #aigd or the ,balanced ,budget and ,emergency ,deficit ,control ,act of #aihe1 and the amount transferred to the ,fund shall be reduced by the same amount4 7d7 ,food and ,drug ,administration ,the entirety of the funds made available pursuant to subsection 7c77#a7 shall be for the ,commissioner of ,food and ,drugs1 pursuant to applicable authorities in the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bja et seq47 or this ,act and other applicable ,federal law1 to support widespread innovation in non-opioid and non-addictive medical products for pain treatment1 access to opioid addiction treatments1 appropriate use of approved opioids1 and efforts to reduce illicit importation of opioids4 ,such support may include the following programs and activities3 7#a7 ,obligating contract funds beginning in fiscal year #bjai for an educational campaign that will-- 7,a7 educate patients and their families to differentiate opioid medications2 7,b7 raise awareness about preferred storage and disposal methods2 and 7,c7 inform patients1 families1 and communities about medication-assisted treatment options4 7#b7 ,building the ,food and ,drug ,administration's presence in international mail facilities1 including through-- 7,a7 improvements in equipment and information technology enhancements to identify unapproved1 counterfeit1 or other unlawful pharmaceuticals for destruction2 7,b7 increased and improved surveillance2 7,c7 renovations at international mail facility locations2 and 7,d7 the purchase of laboratory equipment4 7#c7 ,enhancing the identification and targeting of entities offering products and products being offered by such entities for import into the ,united ,states through review and analysis of ,internet websites1 import data1 and other sources of intelligence for purposes of making the best use of the ,food and ,drug ,administration's inspection and analytical resources4 7#d7 ,increasing the number of staff of the ,food and ,drug ,administration to increase the number of packages being examined1 ensuring the safety of the staff undertaking such examinations1 and ensuring that packages identified as illegal1 counterfeit1 misbranded1 or adulterated are removed from commerce through available authorities1 including administrative destruction4 7#e7 ,enhancing the ,food and ,drug ,administration's criminal investigations resources 7including full-time equivalent employees and equipment71 imports surveillance1 and international work4 7#f7 ,obtaining for the ,food and ,drug ,administration equipment and full-time equivalent employees needed to efficiently screen and analyze products offered for import1 including by building data libraries of new substances and analogues to facilitate identification and evaluation of pharmaceutical-based agents and by purchasing screening technologies for use at international mail facilities4 7#g7 ,operating the ,food and ,drug ,administration's forensic laboratory facility to ensure adequate laboratory space and functionality for additional work and full-time equivalent employees4 7e7 ,accountability and oversight 7#a7 ,work plan 7,a7 ,in general ,not later than #ahj days after the date of enactment of this ,act1 the ,commissioner of ,food and ,drugs shall submit to the ,committee on ,health1 ,education1 ,labor and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives1 a work plan including the proposed allocation of funds appropriated pursuant to the authorization of appropriations under subsection 7c7 for each of fiscal years #bjai through #bjbc and the contents described in subparagraph 7,b74 7,b7 ,contents ,the work plan submitted under subparagraph 7,a7 shall include-- 7i7 the amount of money to be obligated or expended out of the ,fund in each fiscal year for each program and activity described in subsection 7d72 and 7ii7 a description and justification of each such program and activity4 7#b7 ,reports 7,a7 ,annual reports ,not later than ,october #a of each of fiscal years #bjbj through #bjbd1 the ,secretary of ,health and ,human ,services shall submit to the ,committee on ,health1 ,education1 ,labor and ,pensions of the ,senate and the ,committee on ,energy and ,commerce of the ,house of ,representatives a report that includes-- 7i7 the amount of money obligated or expended out of the ,fund in the prior fiscal year for each program and activity described in subsection 7d72 7ii7 a description of all programs and activities using funds provided pursuant to the authorization of appropriations under subsection 7c72 and 7iii7 how the programs and activities are advancing public health4 7,b7 ,additional reports ,at the request of the ,committee on ,health1 ,education1 ,labor and ,pensions of the ,senate or the ,committee on ,energy and ,commerce of the ,house of ,representatives1 the ,commissioner shall provide an update in the form of testimony and any additional reports to the respective congressional committee regarding the allocation of funding under this section or the description of the programs and activities undertaken with such funding4 7f7 ,limitations ,notwithstanding any transfer authority authorized by this section or any appropriations ,act1 any funds made available pursuant to the authorization of appropriations under subsection 7c7 may not be used for any purpose other than the programs and activities described in subsection 7d7 to strengthen and facilitate the ,food and ,drug ,administration's efforts to address the opioid and substance use epidemic4 7g7 ,sunset ,this section shall expire on ,september #cj1 #bjbb1 except that-- 7#a7 this subsection does not apply to reporting under subsection 7e77#b72 and 7#b7 this section shall remain in effect until such time1 and to such extent1 as may be necessary for the funds transferred by subsection 7b77#b7 to be fully expended4 4 #f4 ,consideration of potential for misuse and abuse required for drug approval 7a7 ,in general ,section #eje7;d7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;d77 is amended-- 7#a7 in the first sentence-- 7,a7 by striking or 7#g7 and inserting 7#g72 and 7,b7 by inserting or 7#h7 if the drug is or contains a controlled substance for which a listing in any schedule is in effect under the ,controlled ,substances ,act or that is permanently scheduled pursuant to section #bja of such ,act1 on the basis of information submitted to him as part of the application1 or upon the basis of any other information before him with respect to such drug1 the drug is unsafe for use due to the risks of abuse or misuse or there is insufficient information to show that the drug is safe for use considering such risks2 before he shall issue an order refusing to approve the application2 and 7#b7 in the second sentence1 by striking 7#f7 and inserting 7#h74 7b7 ,withdrawal authority ,section #eje7;e7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;e77 is amended in the first sentence-- 7#a7 by striking or 7#e7 and inserting 7#e72 and 7#b7 by inserting the following3 2 or 7#f7 that1 in the case of a drug that is or contains a controlled substance for which a listing in any schedule is in effect under the ,controlled ,substances ,act or that is permanently scheduled pursuant to section #bja of such ,act1 on the basis of new information before him with respect to such drug1 evaluated together with the information available to him when the application was approved1 that the drug is unsafe for use due to the risks of abuse or misuse after of a material fact4 7c7 ,rule of construction ,nothing in the amendments made by this section shall be construed to limit or narrow1 in any manner1 the meaning or application of the provisions of paragraphs 7#a71 7#b71 7#c71 7#d71 7#e71 and 7#g7 of section #eje7;d7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;d77 or paragraphs 7#a7 and 7#b7 of section #eje7;e7 of such ,act 7#ba ,u4,s4,c4 #cee7;e774 ,passed the ,house of ,representatives ,june #ab1 #bjah4;,clerk4